Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RHK Capital is a boutique investment banking firm that provides a range of financial advisory and capital raising services to small and micro-cap companies. The firm maintains a specialized focus on the healthcare, life sciences, and technology sectors, assisting emerging growth companies in navigating complex capital markets. Their core services include managing initial public offerings (IPOs), follow-on offerings, and private placements of equity and debt. Additionally, RHK Capital provides strategic merger and acquisition (M&A) advisory to help clients achieve long-term corporate objectives. By leveraging deep industry expertise and a broad network of institutional investors, the firm supports the development of innovative medical and technological advancements. RHK Capital is headquartered in New York and operates as a registered broker-dealer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RHK Capital.